Skip to Main content Skip to Navigation
New interface
Journal articles

Tacrolimus: Does direct glucuronidation matter? An analytical and pharmacological perspective

Abstract : Tacrolimus, the gold standard of immunosuppressive treatment indicated to prevent graft rejection in solid organ recipients, is extensively metabolized. While impact of phase I metabolism on the drug pharmacokinetics has been widely discussed, little is known on its glucuronidation mediated by uridine diphosphate glucuronyltransferases (UGT). The impact of glucuronidation in the field of therapeutic drug monitoring might be underestimated mainly because glucuronide metabolite is presumed to be a non-active and short half-life drug.As part of an on-going pharmacokinetic study conducted in our center (CYPTAC’H, NCT01388387) we performed extensive kinetic profiles of tacrolimus whole-blood concentrations in liver transplant recipient patients.
Document type :
Journal articles
Complete list of metadata

Cited literature [4 references]  Display  Hide  Download
Contributor : Laurent Jonchère Connect in order to contact the contributor
Submitted on : Wednesday, May 16, 2018 - 9:54:07 AM
Last modification on : Wednesday, March 30, 2022 - 2:38:25 PM
Long-term archiving on: : Tuesday, September 25, 2018 - 5:43:13 PM


Tron et al. - Tacrolimus Does ...
Files produced by the author(s)



C. Tron, A. Petitcollin, M.-C. Verdier, M. Rayar, J.-M. Beaurepaire, et al.. Tacrolimus: Does direct glucuronidation matter? An analytical and pharmacological perspective. Pharmacological Research, 2017, 124, pp.164-166. ⟨10.1016/j.phrs.2017.03.027⟩. ⟨hal-01614704⟩



Record views


Files downloads